Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2008Journal of Clinical Investigation

CD133 expression is not restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells initiate tumors

View Full Paper
Ask AI
Bookmark
Share

Authors

SSSergey V. ShmelkovNYU Langone HealthJBJason M. ButlerRoyal Brisbane and Women's HospitalAHAndrea T. HooperRegeneron (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Shmelkov et al. (2008) studied this question.

synapsesocial.com/papers/6a0cb93a660334d4fdeb20b9https://doi.org/10.1172/jci34401
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal Cancer2005 · 419 citations
  2. 2Isolation and Characterization of Multipotent Progenitor Cells from the Bowman’s Capsule of Adult Human Kidneys2006 · 745 citations
  3. 3Prospective identification of tumorigenic breast cancer cells2003 · 10,470 citations
  4. 4Conserved markers of fetal pancreatic epithelium permit prospective isolation of islet progenitor cells by FACS2006 · 155 citations
  5. 5Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.1996 · 1,148 citations